VITAMIN-E SUCCINATE INDUCES FAS-MEDIATED APOPTOSIS IN ESTROGEN RECEPTOR-NEGATIVE HUMAN BREAST-CANCER CELLS

Citation
Jm. Turley et al., VITAMIN-E SUCCINATE INDUCES FAS-MEDIATED APOPTOSIS IN ESTROGEN RECEPTOR-NEGATIVE HUMAN BREAST-CANCER CELLS, Cancer research, 57(5), 1997, pp. 881-890
Citations number
61
Categorie Soggetti
Oncology
Journal title
ISSN journal
00085472
Volume
57
Issue
5
Year of publication
1997
Pages
881 - 890
Database
ISI
SICI code
0008-5472(1997)57:5<881:VSIFAI>2.0.ZU;2-9
Abstract
Vitamin E succinate (VES), a derivative of the fat-soluble vitamin D-a lpha-tocopherol (vitamin E), inhibited growth and induced apoptotic ce ll death of estrogen receptor-negative human breast cancer cells, VES- induced apoptosis in MDA-MB-231 and SKBR-3 cells occurred through a Fa s pathway, Total protein levels of the Fas receptor (Fas; APO-1/CD-95) and the Fas Ligand (Fas-L) were increased following VES treatment, In addition, VES increased cell surface Fas expression, Fas-neutralizing antibodies and Fas-L antisense oligonucleotides blocked VES-induced a poptosis, The presence of Fas-L antisense oligonucleotides also comple tely blocked the VES-mediated increase in Fas-L protein expression. Th ese data indicate a role for Fas signaling in VES-mediated apoptotic c ell death of human breast cancer cells. These findings also suggest th at VES may be of clinical use in the treatment of aggressive human bre ast cancers, particularly those that are refractory to antiestrogen th erapy.